Should intervertebral disc degeneration be treated with mesenchymal stem cells?
AnesthesiaExam Podcast · David Rosenblum, MD
November 8, 202216m 22s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A review of the evidence David Rosenblum, MD reviews the description and evidence provided by Loibi et al in the published article referenced below. Dr. Rosenblum discusses personal experiences with treating back pain with regenerative medicine procedures. Discussed in this podcast: Patient selection Pathophysiology Environment of the disc and it's impact on MSCs Risks and safety concerns of Intervertebral mesenchymal stem cell transplantation Pain relief and recommendations for MSC injection into the disc in patients suffering from discogenic pain Claim CME Credit The CE experience for this Podcast is powered by CMEfy - click here to reflect and earn credits: https://earnc.me/WAltmH Course Calendar
- Ultrasound Training Dominican Republic- November 12, 2022
- Physician Networking Event- November 17, 2022
- Ultrasound Training NYC- December 3, 2022
- Regenerative Interventional Pain Course January 28th, 2023
- Ultrasound Training Costa Rica- February 29, 2023
References
Loibl, M, Wuertz-Kozak, K, Vadala, G, Lang, S, Fairbank, J, Urban, JP. Controversies in regenerative medicine: Should intervertebral disc degeneration be treated with mesenchymal stem cells? JOR Spine. 2019; 2:e1043. https://doi.org/10.1002/jsp2.1043